About Marie Guillou

This author has not yet filled in any details.
So far Marie Guillou has created 383 blog entries.

Dermatitis herpetiformis guidelines – S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by EADV

2024-09-16T14:55:45+02:00

Dermatitis herpetiformis guidelines – S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV).

Dermatitis herpetiformis guidelines – S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by EADV2024-09-16T14:55:45+02:00

QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study

2024-10-01T10:49:47+02:00

Publication - Epub 2020 Sep 16. QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study [...]

QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study2024-10-01T10:49:47+02:00

Initial validation of the epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life questionnaire

2024-10-01T10:50:35+02:00

Publication - Epub 2020 Sep 7. Initial validation of the epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life questionnaire [...]

Initial validation of the epidermolysis bullosa-specific module of the Infants and Toddlers Dermatology Quality of Life questionnaire2024-10-01T10:50:35+02:00

Development of an international core domain set for medium, large and giant congenital melanocytic naevi as a first step towards a core outcome set for clinical practice and research

2024-10-16T11:15:33+02:00

Publication - Epub 2020 Nov 25. Development of an international core domain set for medium, large and giant congenital melanocytic naevi as a first step [...]

Development of an international core domain set for medium, large and giant congenital melanocytic naevi as a first step towards a core outcome set for clinical practice and research2024-10-16T11:15:33+02:00

Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology

2024-10-01T10:17:24+02:00

Publication - Nov 2020. Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology Authors Ninavan Beek, [...]

Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology2024-10-01T10:17:24+02:00

Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility

2024-10-01T10:51:56+02:00

Publication - Epub 2020 Mar 11. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility Authors C Has, [...]

Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility2024-10-01T10:51:56+02:00

Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic-Consensus: Recommendations by an international panel of experts

2024-10-01T10:52:53+02:00

Publication - Epub 2020 Jul 16. Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic-Consensus: Recommendations by an international panel of experts [...]

Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic-Consensus: Recommendations by an international panel of experts2024-10-01T10:52:53+02:00